Game Changers in HIV Care: Ligia Peralta, M.D.

Game Changers in HIV Care: Ligia Peralta, M.D.

Ligia Peralta, M.D., does more than just give her adolescent patients a pill. She gives them hope, job opportunities, and -- most importantly -- the tools to fight for better HIV health care.

This Week in HIV Research: One Step at a Time

June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.

By Barbara Jungwirth and Myles Helfand

Ending the HIV Epidemic Will Take More Than Medicine

Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.

By Stephaun E. Wallace, Ph.D.

New Website Helps People Trying to Navigate Their PrEP Options

A team led by Shannon Weber, M.S.W., has developed PleasePrEPMe, an online PrEP provider search and chat service.

By Terri Wilder, M.S.W.

Our Newest Posts

Hormonal Contraception Does Not Increase HIV Risk, Study Finds

No meaningful difference was found in either injectable or implant birth control when compared to an IUD.

By Sony Salzman

HIV Advocacy Group Spars With Express Scripts Over HIV Drug Formulary Changes

Starting July 1, some HIV meds that are widely used will be excluded from their list.

By Sony Salzman

HIV Testing Among Black Gay and Bisexual Men Remains 'Suboptimal,' Study Finds

Black men who have sex with men test in high numbers over a lifetime, but not frequently or recently.

By Stephen Hicks

Initiative Amplifies Voices of Women Scientists in News Media

"I would like to dispel the notion that scientists in general are old white men in lab coats," said HIV researcher Zandrea Ambrose, Ph.D, a participant in the "500 Women Scientists" movement.

By Sony Salzman

This Week in HIV Research: The Racism of Perceived Risk

June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.

By Barbara Jungwirth and Myles Helfand

Refer your clients and patients to TheBody, TheBodyPro's sibling site for people living with or affected by HIV. TheBody delivers vital information, news, support, and personal perspectives on HIV and related issues.